Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies
Wei Shi, Yin Wang, Yuehui Zhao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Tumor-intrinsic regulators of the immune-cold microenvironment of prostate cancer
Lourdes Brea, Jindan Yu
Trends in Endocrinology and Metabolism (2025)
Closed Access | Times Cited: 4
Causal relationship between immune cells and prostate cancer: a Mendelian randomization study
Zhipeng Ye, Xinpei Deng, Jinhui Zhang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 15
The combination of immune checkpoint inhibitors and antibody-drug conjugates in the treatment of urogenital tumors: a review insights from phase 2 and 3 studies
Puguang Yu, Chunming Zhu, Xiangyun You, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 10
Small Extracellular Vesicle piR-hsa-30937 Derived from Pancreatic Neuroendocrine Neoplasms Upregulates CD276 in Macrophages to Promote Immune Evasion
Yuan Zhong, Ye Tian, Yan Wang, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 7, pp. 840-853
Open Access | Times Cited: 7
B7-H3: a robust target for immunotherapy in prostate cancer
Rafael Pulido, José I. López, Caroline E. Nunes‐Xavier
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 584-587
Open Access | Times Cited: 7
Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer
Bilal Unal, Omer F. Kuzu, Yang Jin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies
Carly D. Miller, John R. Lozada, Nicholas A. Zorko, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 5, pp. 1369-1379
Open Access | Times Cited: 5
Interactions between key genes and pathways in prostate cancer progression and therapy resistance
Fan Wu, Hengsen Zhang, Miaomiao Hao
Frontiers in Oncology (2025) Vol. 15
Open Access
TP53 Deficiency in the Natural History of Prostate Cancer
Heidemarie Ofner, Gero Kramer, Shahrokh F. Shariat, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 645-645
Open Access
A brief sketch on antiprostate cancer activity of plant phenolics
Kapil Kumar, Nandini Pathak, Eram Fatima, et al.
Elsevier eBooks (2025), pp. 69-153
Closed Access
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer
Xiaolin Zhu, Chien‐Kuang Cornelia Ding, Rahul Aggarwal
Current Oncology Reports (2025)
Closed Access
PCBP2 promotes immune evasion via cGAS-STING pathway in biochemical recurrence of prostate cancer
Zeng Zhou, Tiewen Li, Y. Zhang, et al.
APL Bioengineering (2025) Vol. 9, Iss. 1
Open Access
Unveiling Transcriptional Mechanisms of B7-H3 in Breast Cancer Stem Cells Through Proteomic Approaches
Yu Ri Seo, Han Byeol Kim, Hyeryeon Jung, et al.
iScience (2025) Vol. 28, Iss. 4, pp. 112218-112218
Open Access
Establishing a Prognostic Model Correlates to Inflammatory Response Pathways for Prostate Cancer via Multiomic Analysis of Lactylation‐Related Genes
Qinglong Du, Chen Meng, Wenchao Zhang, et al.
International Journal of Genomics (2025) Vol. 2025, Iss. 1
Open Access
Targeting B7-H3 inhibition-induced activation of fatty acid synthesis boosts anti-B7-H3 immunotherapy in triple-negative breast cancer
Ying Jiang, Zhiwen Qian, C Wang, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010924-e010924
Open Access
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity
Yun Huang, Wen-Qing Zhong, Xiaoyu Yang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
Bisheng Cheng, Hai Huang
Cancer Biology and Medicine (2023), pp. 1-7
Open Access | Times Cited: 10
The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages
Robin Park, James Yu, Moazzam Shahzad, et al.
Immunologic Research (2024) Vol. 72, Iss. 4, pp. 526-537
Closed Access | Times Cited: 3
ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer
Zhonglin Cai, Xiuxia Zhai, Xiaoxue Xu, et al.
Neoplasia (2024) Vol. 57, pp. 101049-101049
Closed Access | Times Cited: 2
Exploiting the DNA Damage Response for Prostate Cancer Therapy
Travis H. Stracker, Oloruntoba I. Osagie, Freddy E. Escorcia, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 83-83
Open Access | Times Cited: 6
Establishment of a pathomic-based machine learning model to predict CD276 (B7-H3) expression in colon cancer
Jia Li, Dongxu Wang, Chenxin Zhang
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 1
Tumor-associated antigen targets for novel immune-based strategies in prostate cancer
Amman Bhasin, Patrick Mille, Aditya Eturi, et al.
Journal of Translational Genetics and Genomics (2024) Vol. 8, Iss. 1, pp. 55-76
Open Access | Times Cited: 1
Enhancing surgical outcomes: accurate identification and removal of prostate cancer with B7-H3-targeted NIR-II molecular imaging
Yaqi Tian, Hongliang Shen, Lingbing Li, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 9, pp. 2569-2582
Closed Access | Times Cited: 1
Mechanism of baicalein in treatment of castration-resistant prostate cancer based on network pharmacology and cell experiments
Baokai Dou, Yingjie Cui, Qianqian Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Mechanisms of Immune Evasion in PTEN Loss Prostate Cancer
Jorge Esteban-Villarrubia, Pablo Álvarez Ballesteros, Miguel Martín-Serrano, et al.
Immuno (2024) Vol. 4, Iss. 4, pp. 444-460
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top